Upjohn responds to Consumer Reports letter.
Jonas
J M
JM
D000525:Alprazolam / Q000009:adverse effects / Q000493:pharmacokinetics / Q000627:therapeutic use*; D001008:Anxiety Disorders / Q000188:drug therapy* / Q000523:psychology; D002986:Clinical Trials as Topic; D004345:Drug Industry; D004363:Drug Utilization; D006801:Humans; D016584:Panic Disorder / Q000188:drug therapy* / Q000523:psychology; D014481:United States
D000525:Alprazolam